These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 7643912)

  • 21. Contribution of sulfate conjugation, deamination, and O-methylation to metabolism of dopamine and norepinephrine in human brain.
    Rivett AJ; Eddy BJ; Roth JA
    J Neurochem; 1982 Oct; 39(4):1009-16. PubMed ID: 6956674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predominance of oxidative deamination in the metabolism of exogenous noradrenaline by the normal and chemically denervated human uterine artery.
    Branco D; Caramona M; Martel F; de Almeida JA; Osswald W
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Sep; 346(3):286-93. PubMed ID: 1407015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of monoamine oxidase and catechol O-methyltransferase inhibitors on the accumulation and metabolism of [l-3H] norepinephrine by the adventitia and media of rabbit aorta.
    Levin JA; Wilson SE
    J Pharmacol Exp Ther; 1977 Dec; 203(3):598-609. PubMed ID: 925961
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies of monoamine oxidase and semicarbazide-sensitive amine oxidase. I. Inhibition by a selective monoamine oxidase-B inhibitor, MD 780236.
    Kinemuchi H; Morikawa F; Ueda T; Arai Y
    Jpn J Pharmacol; 1986 Jun; 41(2):183-9. PubMed ID: 3747265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A and B forms of monoamine oxidase within the monoaminergic neurons of the rat brain.
    Fagervall I; Ross SB
    J Neurochem; 1986 Aug; 47(2):569-76. PubMed ID: 3734795
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of selective monoamine oxidase inhibitors on the in vivo release and metabolism of dopamine in the rat striatum.
    Butcher SP; Fairbrother IS; Kelly JS; Arbuthnott GW
    J Neurochem; 1990 Sep; 55(3):981-8. PubMed ID: 2117053
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduction of fat deposition by combined inhibition of monoamine oxidases and semicarbazide-sensitive amine oxidases in obese Zucker rats.
    Carpéné C; Iffiú-Soltesz Z; Bour S; Prévot D; Valet P
    Pharmacol Res; 2007 Dec; 56(6):522-30. PubMed ID: 17977742
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Limitation of adipose tissue enlargement in rats chronically treated with semicarbazide-sensitive amine oxidase and monoamine oxidase inhibitors.
    Carpéné C; Abello V; Iffiú-Soltész Z; Mercier N; Fève B; Valet P
    Pharmacol Res; 2008 Jun; 57(6):426-34. PubMed ID: 18539478
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deamination of newly-formed dopamine in rat renal tissues.
    Fernandes MH; Pestana M; Soares-da-Silva P
    Br J Pharmacol; 1991 Mar; 102(3):778-82. PubMed ID: 1364853
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Different metabolism of norepinephrine and epinephrine by catechol-O-methyltransferase and monoamine oxidase in rats.
    Eisenhofer G; Finberg JP
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1242-51. PubMed ID: 8138937
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The fate of [3H]-(-)-noradrenaline in the perfused rat liver.
    Martel F; Azevedo I
    J Auton Pharmacol; 1995 Oct; 15(5):309-19. PubMed ID: 8744971
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of high single doses of levodopa and carbidopa on brain dopamine and its metabolites: modulation by selective inhibitors of monoamine oxidase and/or catechol-O-methyltransferase in the male rat.
    Männistö PT; Tuomainen P
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Oct; 344(4):412-8. PubMed ID: 1766471
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma normetanephrine for examination of extraneuronal uptake and metabolism of noradrenaline in rats.
    Eisenhofer G
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Mar; 349(3):259-69. PubMed ID: 8208304
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unusual pattern of beta-phenylethylamine deamination in the rat heart.
    Tiago Guimarães J; Soares-da-Silva P
    Neurobiology (Bp); 2000; 8(1):109-18. PubMed ID: 11008882
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of monoamine oxidase in the metabolism of exogenous noradrenaline by the human saphenous vein.
    Branco D; Caramona M; Araújo D; Osswald W
    Fundam Clin Pharmacol; 1992; 6(3):145-52. PubMed ID: 1628876
    [TBL] [Abstract][Full Text] [Related]  

  • 36. N-propargylbenzylamine, a major metabolite of pargyline, is a potent inhibitor of monoamine oxidase type B in rats in vivo: a comparison with deprenyl.
    Karoum F
    Br J Pharmacol; 1987 Feb; 90(2):335-45. PubMed ID: 3103805
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Veratridine-induced outward transport of 3H-noradrenaline from adrenergic nerves of the rat vas deferens.
    Bönisch H; Trendelenburg U
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Dec; 336(6):621-30. PubMed ID: 3444479
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential substrate specificity of monoamine oxidase in the rat heart and renal cortex.
    Guimarães JT; Vindis C; Soares-da-Silva P; Parini A
    Life Sci; 2003 Jul; 73(8):955-67. PubMed ID: 12818349
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 1,1'-Diisopropyl-2,4'-cyanine (disprocynium24), a potent uptake2 blocker, inhibits the renal excretion of catecholamines.
    Graefe KH; Friedgen B; Wölfel R; Bossle F; Russ H; Schömig E
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Jul; 356(1):115-25. PubMed ID: 9228198
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of inhibitors of extraneuronal uptake on the distribution of 3H-(+/-)noradrenaline in nerve-free rabbit aortic strips.
    Eckert E; Henseling M; Trendelenburg U
    Naunyn Schmiedebergs Arch Pharmacol; 1976 May; 293(2):115-27. PubMed ID: 958502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.